Source: International Congress 2018 – Malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Scherpereel (Lille, France). What is the best oncological management strategy for mesothelioma in 2018?. International Congress 2018 – Malignant pleural effusions

Member's Comments

No comment yet.

Related content which might interest you: Multidisciplinary mesothelioma treatment: practical aspects including palliative care Source: Annual Congress 2009 - MP10 - Multidisciplinary mesothelioma treatment: practical aspects including palliative care Year: 2009 Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014 In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment? Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Approaches to radiological staging of mesothelioma relating to modern treatment modalities Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 The effectiveness of a multidisciplinary approach in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 How to improve diagnosis and care for mesothelioma patients in Europe Source: International Congress 2019 – Rare lung diseases Year: 2019 Quality management in thoracic oncology: how do patients and clinicians benefit? Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe Year: 2012 The use of surgical services in the management of suspected lung cancers Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Surgery for mesothelioma: is curative surgery the past or the future? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014 Immunotherapy: a new standard of care in thoracic malignancies? Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017 Year: 2018 Practical tools for implementing early palliative care in advanced lung cancer Source: Eur Respir J 2016; 47: 1010-1012 Year: 2016 Diagnostic-therapeutic sequences in advanced NSCLC: how to best standardise and personalise your strategies Source: International Congress 2017 – The latest in lung cancer Year: 2017 Which tools to improve early diagnosis of COPD in primary care? Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Identifying pan-European treatment goals for the primary care management of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this? Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Contemporary management of malignant mesothelioma Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases Year: 2004